UConn Health Center HomeGraduate School
HOME DEGREE PROGRAMS EVENTS FAQS CONTACT US

Faculty Directory

< Back to Faculty Directory

Henry Smilowitz

Associate Professor of Cell Biology
smilowitz@nso1.uchc.edu
860-679-2710

Henry Smilowitz
Areas of Interest

a. Use of gold nanoparticles for tumor imaging, vascular imaging and as a radiation enhancer for tumor therapy.

b. Development of novel brain tumor therapies for experimental, advanced, imminently lethal intracerebral malignant gliomas and melanomas in rats and mice using a combination of radiation therapy and immunotherapy. 

Lab Rotation Projects

Our laboratory is involved in a number of research projects in the fields of cancer, cancer immunotherapy, cancer therapy, tumor and vascular imaging, as can be seen by the following publications. Please contact the Smilowitz Lab for specific projects.
1. Gold Enhanced Radiation Therapy & Vascular and Tumor Imaging:
We are working collaboratively with a company on Long Island that has developed novel preparations of gold nano-particles. These non-toxic particles can be injected iv at very high doses and small particles are excreted by the kidney. We are working on several projects to develop novel therapies and diagnostic tests that can be performed with these agents:

Gold Enhanced Radiation Therapy: We have shown that gold nanoparticles can greatly increase the radiation dose a tumor receives and are therefore useful as radiation enhancers. We are currently working on breast cancer, squamous cell carcinoma and glioma models.
Gold Enhanced Imaging: We are working on several imaging projects including the development of a virtual colonoscopy, breast cancer imaging, gold-based angiography, and kidney imaging.

2. Experimental Therapeutics of Brain Tumors:
We introduce glioma or melanoma cells into rat or mouse brains and allow the tumors to occupy about 2% of the brain (analogous to human brain tumors at the time of diagnosis) before therapy is started. We first treat with a form of radiation therapy followed by a form of experimental immunotherapy under development. A variety of immunological assays are performed in addition to survival studies.

Publications

Selected Publications

Hainfeld, J.F., O’Connor, M.J., Dilmanian, F.A., Slatkin, D.N., Adams, D.J., Smilowitz, H.M. 2011. MicroCT Enables Microlocalization and Quantification of Her-2-Targeted Gold Nanoparticles Within Tumor Regions. British Journal of Radiology, Epub Ahead of Print.

Hainfeld, J.F., O’Connor, M.J., Lin, P.P., Smilowitz, H.M. 2010 Cancer Therapy with wIRA and Gold Nanoparticles. Water-Filtered Infrared-A Radiation: From Basic Principles to Clinical Applications.

Stoklasek, T., Colpitts, SL, Smilowitz, H.M. and Lefrancois, L 2010. MHC Class I and TCR Avidity Control the CD8 T Cell Response to IL15/IL15Ralpha Complex J. Immunol. 185: 6857-6865.

Hainfeld, J.F., Dilmanian, F.A., Zhong Z., Slatkin, D.N., Smilowitz, H.M. 2010 Gold Nanoparticles Enhance Radiation Therapy of a Squamous Cell Carcinoma Growing in Mice. Physics in Medicine and Biology, 55: 1-15

Hainfeld, J.F., Slatkin, D.N., Dilmanian, F.A., Smilowitz, H.M. 2008. Radiotherapy Enhancement with Gold Nanoparticles. J. Pharmacy and Pharmacology. 60: 977-985. Volume 60 #8 is a Special Issue: Radiation Biology – Can New Concepts Achieve Better Treatment Outcomes?

Smilowitz, H.M., Weissenberger, J.,O'Neill, R.,Brown, J., Weis , J. and Laissue, J.A. 2007. Orthotopic Transplantation of v-src Expressing Glioma Cell Lines into Immunocompetent Mice: Establishment of a New Transplantable in vivo Model for Malignant Gliomas. J. Neurosurgery 106: 1-8.

Smilowitz, H.M., T. Graham, M. Ji, G. Tellides, M. Oaks, J.F. Hainfeld, D.N. Slatkin. 2007. The combination of x- ray - mediated radiosurgery and immunoprophylaxis for advanced intracerebral F98 gliomas in rats: efficacy of Treg depletion and uric acid. Centenial meeting of the American Association for Cancer Research April 14-18, 2007, Los Angeles, California.

Hainfeld, J.F., D.N. Slatkin, T. Focella, H.M. Smilowitz. 2006. Gold Nanoparticles as X-Ray contrast Agents. British Journal of Radiology. 79: 248-253.

Smilowitz, H.M., D.N. Slatkin, N. Lubimova, H. Blattman, E. Brauer-Krisch, A. Bravin, M. Di Michiel, J. Stepanek, G. Le Duc, J.-O. Gebbers, J.A. Laissue. 2006. Synergy of Gene-Mediated Immunoprophylaxis and Microbeam Radiation Therapy (MRT) for Advanced Intracerebral Rat 9L Gliosarcomas. J. Neuro-Oncology 78:135-143.

Hainfeld, J.F., D.N. Slatkin, H.M. Smilowitz. 2004, Gold Nanoparticles Greatly Enhance X-ray Cancer Therapy in Mice. Physics in Medicine and Biology 49: N309.

Smilowitz, H.M., Coderre, J.A., Nawrocky, M.M., Pinkerton, A., Tu, W., Slatkin, D.N. 2002. The Combination of X-Ray-Mediated Radiosurgery and Gene Mediated Immunoprophylaxis for an Advanced Intracerebral Gliosaracoma in Rats. J. NeuroOncology 57: 9-18.

Paper icon View more publications, see Pubmed listing.

rev. 4/11

  
A-Z INDEX        UCONN HEALTH CENTER        TEXT-ONLY © University of Connecticut Health Center
Disclaimer   Privacy Notice
Maps & Directions